Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 17 Sept 2026 for INCYTE CORP, €158k. Read the official filing
Filing timeline
BuySalePablo J. Cagnoni
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Pablo J. Cagnoni: trading record in brief
Pablo J. Cagnoni discloses dealings in 2 companies, chiefly Incyte Corp and Rubius Therapeutics, Inc. Between 29 January 2022 and 15 September 2026, the trades on record add up to 28 filings.
The open-market record consists of 8 sales worth €9.0M, with no purchase. Besides market trades, the filings include 10 share grants and 10 option exercises. Since January 2026: no purchases and 7 sales on the market.
On 17 September 2026 came the latest disclosure, an option exercise for €158k in Incyte Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Pablo J. Cagnoni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
2,957 shares@ US$61.76Common StockSEC:0001205703-26-000030:0
4,551 shares@ US$61.18Common StockSEC:0001205703-26-000030:1
6,477 shares@ US$64.25Common StockSEC:0001205703-26-000030:2
9,233 shares@ US$71.93Common StockSEC:0001205703-26-000030:3
9,233 shares@ US$120.50Common StockSEC:0001205703-26-000030:4
13,985 shares@ US$120.49Common StockSEC:0001205703-26-000030:5
10,801 shares@ US$125.560.0053% mcap8.8% of flowCommon StockSEC:0001205703-26-000028:0
10,803 shares@ US$120.040.0053% mcap9.3% of flowCommon StockSEC:0001205703-26-000027:0
10,640 shares@ US$122.690.0054% mcap10.3% of flowCommon StockSEC:0001205703-26-000025:0
15,888 shares@ US$119.700.0079% mcap16.8% of flowCommon StockSEC:0001205703-26-000023:0
13,403 shares0Common StockSEC:0001205703-26-000021:0
17,969 shares@ US$114.880.0089% mcap22.2% of flowCommon StockSEC:0001205703-26-000019:0
4,950 shares@ US$115.090.0024% mcap6.1% of flowCommon StockSEC:0001205703-26-000019:1
25,469 shares@ US$95.590.011% mcap44.4% of flowCommon StockSEC:0001205703-26-000017:0
6,077 shares@ US$64.250.0017% mcap7.0% of flowCommon StockSEC:0001205703-26-000012:0
12,590 shares@ US$71.930.0040% mcap16.3% of flowCommon StockSEC:0001205703-26-000012:1
18,667 shares@ US$96.500.0080% mcap32.4% of flowCommon StockSEC:0001205703-26-000012:2
27,892 shares0Common StockSEC:0001205703-26-000010:0
7,166 shares@ US$61.187.4% of flowCommon StockSEC:0001205703-26-000008:0
13,093 shares@ US$61.7611.7% of flowCommon StockSEC:0001205703-26-000006:0
1,280 shares@ US$69.981.6% of flowCommon StockSEC:0000879169-25-000086:0
19,851 shares0Common StockSEC:0000879169-24-000134:0
9,668 shares0Common StockSEC:0001209191-23-042551:0
192,400 shares0Common StockSEC:0001209191-23-038745:0
179,613 shares0Common StockSEC:0001209191-23-034977:0
25 of 28 declarations
